GlobeNewsWire
04 Jun 2026, 20:39 UTC · 2h ago
Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
Search tags
GlobeNewsWire
04 Jun 2026, 20:39 UTC · 2h ago
Search tags
Story key points
2 claims · impact-rated
Law firm Bragar Eagel & Squire is seeking a lead plaintiff for a securities litigation action against Regencell Bioscience Holdings Limited (RGC). — The initiation of a securities class action lawsuit typically signals legal risk and potential financial liabilities for the target company.
-0.40The legal action targets investors who purchased Regencell securities between October 28, 2024, and October 31, 2025, and suffered losses. — This defines the scope of the potential liability and confirms that significant losses were sustained by investors during this period.
-0.20Ticker attribution
Model heads
The company is the subject of a legal solicitation for investors who suffered losses.
Continue reading
6 related stories
The company is the subject of a legal solicitation for investors who suffered losses.
The company is the subject of a legal solicitation for investors who suffered losses.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Globe News Wire
2h ago
